BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7044081)

  • 1. Captopril therapy.
    Brosof AB
    Am Fam Physician; 1982 Jun; 25(6):49. PubMed ID: 7044081
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of the overall experience of captopril in hypertension.
    Frohlich ED; Cooper RA; Lewis EJ
    Arch Intern Med; 1984 Jul; 144(7):1441-4. PubMed ID: 6233948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril-associated neutropenia. Who is at risk?
    Cooper RA
    Arch Intern Med; 1983 Apr; 143(4):659-60. PubMed ID: 6340620
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteinuria and abnormalities of the renal glomerulus in patients with hypertension.
    Lewis EJ
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():105-15. PubMed ID: 6754183
    [No Abstract]   [Full Text] [Related]  

  • 5. [New evaluation of captopril-induced side effects].
    Kirchertz EJ; Scheler F
    Dtsch Med Wochenschr; 1982 Mar; 107(9):345-7. PubMed ID: 7037352
    [No Abstract]   [Full Text] [Related]  

  • 6. Captopril vs mild to moderate hypertension.
    Arlington A
    Arch Intern Med; 1985 Jun; 145(6):1141-2. PubMed ID: 3890790
    [No Abstract]   [Full Text] [Related]  

  • 7. What to watch for with captopril.
    Rosenberg JM; Kirschbaum HL
    RN; 1983 Feb; 46(2):56-7. PubMed ID: 6338577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hypertension (IV)].
    Breithaupt H
    Med Welt; 1982 Nov; 33(46):1611-5. PubMed ID: 6759848
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal pancytopenia associated with the use of captopril.
    Gavras I; Graff LG; Rose BD; McKenna JM; Brunner HR; Gavras H
    Ann Intern Med; 1981 Jan; 94(1):58-9. PubMed ID: 7004300
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug corner: capoten (Captopril).
    Jump W
    Crit Care Nurse; 1982; 2(1):64-5, 69. PubMed ID: 7042214
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria during long-term captopril therapy.
    Case DB; Atlas SA; Mouradian JA; Fishman RA; Sherman RL; Laragh JH
    JAMA; 1980 Jul; 244(4):346-9. PubMed ID: 6993700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful reintroduction of captopril following neutropenia.
    Edwards CR; Drury P; Penketh A; Damluji SA
    Lancet; 1981 Mar; 1(8222):723. PubMed ID: 6110936
    [No Abstract]   [Full Text] [Related]  

  • 13. Membranous glomerulopathy and nephrotic syndrome after captopril therapy.
    Sturgill BC; Shearlock KT
    JAMA; 1983 Nov; 250(17):2343-5. PubMed ID: 6355523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril in Takayasu's disease.
    Pirttiaho HI
    Arch Intern Med; 1985 Jan; 145(1):180. PubMed ID: 2857559
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rosea-like rash from captopril.
    Wilkin JK; Kirkendall WM
    Arch Dermatol; 1982 Mar; 118(3):186-7. PubMed ID: 7039511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril: benefits and risks in severe hypertension.
    Lancet; 1980 Jul; 2(8186):129-30. PubMed ID: 6105297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neutropenia induced by low doses of captopril in hypertensive patients without associated autoimmune disease].
    Ortega G; Molina M; Rivera MD; Serrano C
    An Med Interna; 1999 Aug; 16(8):436. PubMed ID: 10507176
    [No Abstract]   [Full Text] [Related]  

  • 18. Captopril-induced membranous glomerulopathy.
    Sunderrajan S; Luger A; Bauer JH
    South Med J; 1983 Oct; 76(10):1294-6. PubMed ID: 6353602
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral captopril solution for neonatal hypertension.
    Iafrate RP; Wall D; Lynch SM
    Clin Pharm; 1983; 2(5):395. PubMed ID: 6354565
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal dose of captopril in hypertension.
    Smith SJ; Markandu ND; MacGregor GA
    Lancet; 1982 Dec; 2(8313):1460. PubMed ID: 6129530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.